BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250927
DTEND;VALUE=DATE:20251002
DTSTAMP:20260830T075510
CREATED:20250711T143956Z
LAST-MODIFIED:20250731T142206Z
UID:100114333-1758931200-1759363199@www.pathologynews.com
SUMMARY:The ERS Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecGet all the latest updates in respiratory medicine and science at the ERS Congress 2025.  \nThis year’s theme is ‘Respiratory health around the globe’. \n\n\n\n\n\n\n\n\n\nThe ERS Congress is the world’s largest and most influential event in respiratory medicine\, bringing together leading clinicians\, researchers\, and healthcare professionals to explore the latest advances in the field. With a rich and diverse programme covering everything from airway diseases and sleep disorders to thoracic oncology and critical care\, the congress offers valuable learning opportunities for professionals at all career stages. \nAttendees can benefit from expert-led symposia\, workshops\, and skills training. The congress also emphasizes patient involvement\, with strong collaboration from the European Lung Foundation. \n\n\n\n\n\n\n\n\nRegister NowMeet our partner
URL:https://www.pathologynews.com/event/the-ers-congress-2025/
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/The-ERS-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250930
DTEND;VALUE=DATE:20251002
DTSTAMP:20260830T075510
CREATED:20250820T090136Z
LAST-MODIFIED:20250820T090136Z
UID:100115156-1759190400-1759363199@www.pathologynews.com
SUMMARY:Precision Medicine: Redefining the Future of Healthcare
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\n\n\nDelivering Personalized Treatments\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJoin Biomarkers & Precision Medicine UK\, an immersive event now in its 20th year\, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies\, pioneering biotech firms & startups\, and leading academic & healthcare institutions\, all contributing to various therapeutic areas and stages of drug development\, clinical trials\, and precision patient treatments. \n\n\n\n\nWhat is Biomarkers & Precision MedicineTargeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments. \nAre you ready to participate in this shared opportunity? Do you have the knowledge\, strategy\, tools and connections in place? \nPrecision Medicine provides the platform for you to learn\, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma\, biotech\, academia and healthcare. \nBiomarkers & Precision Medicine UK\, takes place on September 30-1 October in London\, UK. Running across two full days\, with 16 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market \nRegister Now\n\n\n\n\n\n\n\n\n\nWhy attend?\n\n\n\n\n\n\n\n\n\n\n\n\nExpand your knowledge\nLet subject specialists take you further and deeper.\nWith comprehensive learning in oncology\, neuroscience and key complementary areas. \nBuild the partnerships you need\nIdentify\, meet and collaborate with the people your strategy requires.\nStart working with those who share your goals with 200 hours of pre-arranged 1-2-1s. \nJoin the conversation\nMeet like-minded peers\, expand your network and engage in interdisciplinary discussion on the latest thinking and practice. \nSee what’s in the pipeline\nOur events are where innovations land.\nBe at the showcase and meet the people behind technologies to give you the edge. \nUnderstand the competitive landscape\nLearn what others in your field are doing.\nEvaluate their successes (and failures) and set your own benchmarks. \nHarness AI & machine learning\nAI & machine-learning tools will be critical in unlocking growth.\nSee the technology in action and speak to those who can help you implement it.
URL:https://www.pathologynews.com/event/precision-medicine-redefining-the-future-of-healthcare/
LOCATION:QEII Centre\, London\, UK\, London\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Precision-Medicine-Redefining-the-Future-of-Healthcare.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251001T150000
DTEND;TZID=Europe/London:20251001T160000
DTSTAMP:20260830T075510
CREATED:20250822T130516Z
LAST-MODIFIED:20250919T113346Z
UID:100115222-1759330800-1759334400@www.pathologynews.com
SUMMARY:Adapt or Fall Behind: Why the Best Labs Use AI
DESCRIPTION:0000Days00Hrs00Min00SecArtificial intelligence is reshaping the lab landscape—not in the future\, but now. In this webinar\, we’ll explore why adopting AI is no longer optional for modern labs and share real-world insights from clinical leaders who have already taken the leap. Learn how labs in anatomic pathology\, microbiology\, cytology\, and more are using AI to impact their staff and the patients they serve—and the lessons they’ve learned along the way. \nPresenter\n\nDr. Chen is a leader in digital and computational pathology\, holding a medical degree from the Mayo Clinic Alix School of Medicine and a master’s in Global Medicine from USC. She completed her anatomic pathology residency at Brigham and Women’s Hospital and an NIH/NCI postdoctoral fellowship in computational pathology at Harvard Medical School and Mass General Brigham. Before joining Techcyte\, Dr. Chen led digital pathology initiatives at a cancer pharmaceutical company\, driving advancements in AI-powered diagnostics.\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/adapt-or-fall-behind-why-the-best-labs-use-ai/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/WhatsApp-Image-2025-08-22-at-12.34.19-PM.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251005
DTEND;VALUE=DATE:20251008
DTSTAMP:20260830T075510
CREATED:20250512T180218Z
LAST-MODIFIED:20250821T092240Z
UID:100111927-1759622400-1759881599@www.pathologynews.com
SUMMARY:Pathology Vision 2025
DESCRIPTION:0000Days00Hrs00Min00SecCONNECT WITH INDUSTRY LEADERS\,\nAND THE FUTURE.\nPathology Visions brings together 800+ experts and peers across the field of digital pathology to address real-world\, practical applications of digital pathology today\, as well as the future of the field through new technologies and developments. \nIf you are a clinician or a researcher\, a technician or a trainee\, PathVisions is the place for you. \nYour industry is changing. Are you keeping up? \nRegister NowLook for SIIM at the Digital Pathology Association (DPA)’s Pathology Visions 2025. \nAttend the SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: form Basic Science to Pragmatic Approaches to Pixels on October 5 and/or come to Booth #103 for a demo of our Virtual Hospital SIIMulator (VHS)\, an online sandbox for DICOM\, HL7\, FHIR. \nSIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: from Basic Science to Pragmatic Approaches to PixelsSun\, Oct 5 \n11:00AM – 12:00PM PT \nSeaport Ballroom \n\nThe Challenges of Digital Pathology Conversion: Transitioning from traditional practices to digital pathology focused around the DICOM standard presents unique challenges\, from system integration to data management. We will discuss these challenges in detail and introduce SIIM’s tools and resources to help pathologists and institutions navigate this conversion. Learn about best practices for overcoming common obstacles\, optimizing workflows\, and ensuring smooth implementation.\nThe Breadth of Research in Pathology Imaging at SIIM: SIIM is at the forefront of imaging informatics research\, including in the field of pathology\, based on successes of imaging standardization in radiology. This segment will explore SIIM’s extensive research efforts that are driving innovation in pathology imaging. We will showcase studies\, collaborations\, and advancements that will shape the future of digital pathology\, with a focus on imaging technologies and their application in diagnostic workflows.\nSIIM’s Commitment to Strategic Technical Leadership and Education in Digital Pathology: As part of our mission to empower imaging professionals\, SIIM can provide strategic leadership and education in digital pathology imaging informatics. This section will highlight our ongoing initiatives to advance technical expertise\, provide training programs\, and support the integration of emerging technologies into pathology practice. Learn how SIIM is paving the way for pathologists.
URL:https://www.pathologynews.com/event/pathology-vision-2025/
LOCATION:Manchester Grand Hyatt\, San Diego\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/PV-San-Diego-Event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251010
DTEND;VALUE=DATE:20251013
DTSTAMP:20260830T075510
CREATED:20250522T130424Z
LAST-MODIFIED:20250603T132950Z
UID:100112813-1760054400-1760313599@www.pathologynews.com
SUMMARY:2nd Annual Congress of Asian Society of Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecPixels to Practice: Advancing Digital Pathology in Asia \nWhat to Expect at ASDP 2025Where Pathology Meets AI: The Future of Diagnostics Begins \nThe Asian Society of Digital Pathology (ASDP) Conference 2025 will serve as a pivotal meeting point for leaders in medicine\, artificial intelligence\, and industry. This event brings together a diverse community of clinicians\, researchers\, technologists\, and decision-makers who are shaping the future of diagnostic practice.— and innovation into impact. \nConference Highlights:\n\nVisionary keynote presentations from internationally recognised pioneers in AI and digital pathology\nGroundbreaking research from leading laboratories and academic institutions\nLive demonstrations showcasing AI tools that are transforming diagnostic workflows\nExpert-led panels addressing regulatory pathways and clinical adoption\nNetworking opportunities with global experts\, innovators\, and healthcare policymakers\n\nWho Should Attend:\nFrom clinicians and computational scientists to regulatory experts and healthcare leaders\, ASDP 2025 offers valuable insights and practical knowledge for anyone driving progress in digital diagnostics. This is where knowledge translates into innovation — and innovation into impact. \nRegister Now
URL:https://www.pathologynews.com/event/2nd-annual-congress-of-asian-society-of-digital-pathology/
LOCATION:JW Marriott Mumbai Sahar\, Mumbai\, India
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/2nd-Annual-Congress-of-Asian-Society-of-Digital-Pathology.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251013T140000
DTEND;TZID=Europe/London:20251013T150000
DTSTAMP:20260830T075510
CREATED:20250929T163601Z
LAST-MODIFIED:20251003T080807Z
UID:100115844-1760364000-1760367600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThe next seminar will take place on Monday\, 13 October\, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC\, The Netherlands\, who will be joining online. \nAbstract\nThe integration of diverse data types—such as histopathology\, radiology\, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk\, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization\, model generalization\, and clinical translation. \nRegister NowBio\nDr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC\, where she leads research at the intersection of deep learning\, digital pathology\, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-towards-multimodal-ai-for-personalized-cancer-treatment/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/09/TIA-Centre-Seminar-Series-Towards-Multimodal-AI-for-Personalized-Cancer-Treatment-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251015T150000
DTEND;TZID=Europe/Paris:20251015T160000
DTSTAMP:20260830T075510
CREATED:20250902T135514Z
LAST-MODIFIED:20251013T141041Z
UID:100115332-1760540400-1760544000@www.pathologynews.com
SUMMARY:Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET\, 2 PM BST\, and 9 AM EST. \nSpatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions\, these tools reveal previously hidden molecular characteristics\, allow for more granular tissue classification\, and address challenges posed by compromised sample quality. \nLearning Objectives:\n\nUnderstand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.\nLearn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.\nCompare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.\n\nRegister NowSpeaker:\nProf. Felix Sahm \nProf. Dr. Dr. med. Felix Sahm\, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology \nUniversity of Heidelberg \nAn internationally recognized expert in brain tumor diagnostics\, he has authored over 500 publications\, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.
URL:https://www.pathologynews.com/event/spatially-resolved-transcriptomics-and-graph-based-deep-learning-improve-accuracy-of-routine-cns-tumor-diagnostics/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/GEN-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251016T160000
DTEND;TZID=Europe/London:20251016T170000
DTSTAMP:20260830T075510
CREATED:20250827T151754Z
LAST-MODIFIED:20250827T152303Z
UID:100115278-1760630400-1760634000@www.pathologynews.com
SUMMARY:Masterclass Webinar: Admin and Metadata Options in HALO Link
DESCRIPTION:0000Days00Hrs00Min00SecLearn how to maximize the efficiency\, customization\, and data management capabilities of your HALO Link deployments!\nSummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency\, customization\, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard\, highlighting tools for managing users\, groups\, and permissions\, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.  \n\nThe webinar will also dive into metadata management\, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments\, this session will equip administrators with practical strategies to tailor HALO Link to their needs\, reduce administrative burden\, and empower users to work more efficiently. \n\nLearning Objectives\nLearn about all the functionality in the current Admin Dashboard in HALO Link \nLearn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing \nLearn about tools to manage users\, permissions\, and user groups \nLearn about creating and managing system metadata fields  \n\nRegister NowPresentKat Latimer\nHALO Link Associate Product Manager\nIndica Labs  \nKat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies\, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression.  In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience. 
URL:https://www.pathologynews.com/event/masterclass-webinar-admin-and-metadata-options-in-halo-link/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/08/Masterclass-Webinar-Admin-and-Metadata-Options-in-HALO-Link.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251017
DTEND;VALUE=DATE:20251022
DTSTAMP:20260830T075510
CREATED:20250710T100115Z
LAST-MODIFIED:20250731T142312Z
UID:100114263-1760659200-1761091199@www.pathologynews.com
SUMMARY:ESMO Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world.\nESMO 2025 will be a place where groundbreaking discoveries\, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care. \nYou will be able to learn from internationally renowned experts\, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis\, treatment and survivorship. \nA comprehensive educational and scientific programme will foster exchange and debate of translational cancer science\, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. \nLearning objectives\n\nTo review and be updated on prevention\, screening and early diagnosis of cancer\nTo be updated on the latest breakthroughs in basic science\, translational and clinical cancer research\nTo analyze and understand the clinical perspective of the scientific advances in cancer biology\, diagnostics\, and new treatments\nTo learn the optimal roles of novel diagnostics and treatments for patients with cancer\n\nRegister NowMeet Our Partner\n\n\n\n\nMeet Mindpeak\, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency. \nCatch them at ESMO 2025 — Booth #4010.  \nDiscover how AI is reshaping the future of oncology. \n\n\n\n\n\n\n\n\nAccreditation\nESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details . \nDisclaimer\nESMO is a scientific and professional\, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs\, invited speakers\, presenters\, members or any other contributor\, formally or informally\, which might cause offence or be perceived as being biased. \nThe experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons. \nAll Speakers and Discussants are required to declare their interests\, if any\, and include a Declaration of Interest (DOI) slide at the start of their presentation(s). \nThe ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
URL:https://www.pathologynews.com/event/esmo-congress-2025/
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/ESMO-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251020
DTEND;VALUE=DATE:20251022
DTSTAMP:20260830T075510
CREATED:20250624T132630Z
LAST-MODIFIED:20250731T142434Z
UID:100113792-1760918400-1761091199@www.pathologynews.com
SUMMARY:Conference on Artificial Intelligence in Medical Imaging
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\nCMIMI is now SIIM-CAIMI!\n\n\n\n\n\n\nNew name. Sharper focus. Same cutting-edge research.\n\n\n\n\n\nUnparalleled Research Focus\n\n\n\n\n\n\nIn-depth talks from top AI and imaging research centers with live Q&A\nA space to test ideas\, challenge norms\, and refine AI approaches\nAccepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine\n\n\n\n\n\n\n\n\nImmersive Scientific Discussions\n\n\n\n\n\n\nDeep dives into methods\, results\, and clinical relevance\nDiscussions on AI bias\, model generalizability\, and regulatory considerations\nCase study-driven conversations connecting theory to real-world impact\n\n\n\n\n\n\n\n\n\n\nA Multidisciplinary Community\n\n\n\n\n\n\nConnect with researchers\, clinicians\, and industry leaders in an intimate setting\nBuild partnerships across academia and industry\nBe part of a welcoming environment for trainees and early-career professionals\n\n\n\n\n\n\n\n\n\n\n\n\nAI in Action – From Research to Real-World Applications\n\n\n\n\n\n\nCutting-edge model development for accuracy and explainability\nReal-world AI integration in imaging workflows\nEthics and regulation for responsible AI deployment\n\n\n\n\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/conference-on-artificial-intelligence-in-medical-imaging/
LOCATION:University of California\, Irvine\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/Conference-on-Artificial-Intelligence-in-Medical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251021T160000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20260830T075510
CREATED:20250827T154822Z
LAST-MODIFIED:20250827T154822Z
UID:100115293-1761062400-1761066000@www.pathologynews.com
SUMMARY:Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
DESCRIPTION:0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!\nSummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently\, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further\, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition\, severely hampering development of therapeutic interventions. Using genomics\, spatial transcriptomics\, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia\, angiogenic and inflamed endothelial cell profiles\, reactive astrocytes\, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly\, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall\, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes. \nLearning Objectives\nUnderstand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases \nUnderstand how HALO AI can be used to identify unique cell populations with complex\, varied shapes \nExplore how genomic data can be validated using histologic images analysis\n\nRegister NowPresenterJonathan Cherry\, PhD \nResearch Health Scientist \nVA Boston Healthcare System \nDirector\, Digital Pathology Core & Research Neuropathologist \nBoston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center \nAssistant Professor of Pathology and Laboratory Medicine\nBoston University Avedisian & Chobanian School of Medicine \nDr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008\, earned his doctoral degree in Pathology from the University of Rochester in 2015\, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.  \nDr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically\, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.  \nDr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease\, chronic traumatic encephalopathy\, frontotemporal lobar degeneration\, motor neuron diseases\, and others. 
URL:https://www.pathologynews.com/event/multi-omics-analysis-demonstrates-repetitive-head-impacts-induce-neuronal-loss-and-neuroinflammation-in-young-athletes/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Multi-Omics-Analysis-Demonstrates-Repetitive-Head-Impacts-Induce-Neuronal-Loss-and-Neuroinflammation-in-Young-Athletes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251023T160000
DTEND;TZID=Europe/London:20251023T170000
DTSTAMP:20260830T075510
CREATED:20251019T084830Z
LAST-MODIFIED:20251019T084830Z
UID:100116283-1761235200-1761238800@www.pathologynews.com
SUMMARY:AISight Dx Digital Pathology Platform: Live Deep Dive
DESCRIPTION:0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale. \nIn this webinar\, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale\, including seamless slide management\, flexible collaboration\, and interoperability across a broad range of whole-slide imaging scanners\, and will explain what PCCP means for ongoing updates and customer value. \nYou’ll also see a live demonstration with case-based examples covering slide navigation\, AISight Live for synchronous and asynchronous collaboration\, annotation tools\, and the caselist dashboard. \nWhat you’ll learn\n\nWhat FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap\nHow pathologists and lab leaders can standardize workflows\, collaborate across teams\, and stay ready for future feature updates enabled under the PCCP\nLive demo: lightning-fast slide navigation and manipulation\, measurements and annotations\, real-time and asynchronous collaboration with AISight Live\, case list triage\, search\, filters\, and workflow handoffs\n\nRegister Now
URL:https://www.pathologynews.com/event/aisight-dx-digital-pathology-platform-live-deep-dive/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AISight-Dx-Digital-Pathology-Platform-Live-Deep-Dive.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251027T140000
DTEND;TZID=Europe/London:20251027T150000
DTSTAMP:20260830T075510
CREATED:20251014T133819Z
LAST-MODIFIED:20251014T133819Z
UID:100116188-1761573600-1761577200@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Tapabrata (Rohan) Chakraborty from UCL\, London\, UK. \nAbstract\nFor AI to be trusted for use in high risk applications like healthcare\, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance. \nRegister NowBio\nRohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL\, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-conformal-quantification-of-predictive-uncertainty-in-health-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-Conformal-Quantification-of-Predictive-Uncertainty-in-Health-AI.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251028T153000
DTEND;TZID=UTC:20251028T163000
DTSTAMP:20260830T075510
CREATED:20250912T085339Z
LAST-MODIFIED:20250912T085339Z
UID:100115449-1761665400-1761669000@www.pathologynews.com
SUMMARY:ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
DESCRIPTION:0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients\, at the right moment\, with the right data. \nWith the launch of Proscia Aperture™\, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies. \nClinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams. \nAnd for everyone attending\, the Partner Expo will feature breakthroughs in pathology AI\, next-generation infrastructure\, and enterprise solutions—delivered by the strongest ecosystem in the industry. \nRegister Now
URL:https://www.pathologynews.com/event/access25-the-future-of-precision-medicine-starts-at-the-moment-of-diagnosis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/The-Future-of-Precision-Medicine-Starts-at-the-Moment-of-Diagnosis.jpg
END:VEVENT
END:VCALENDAR